Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Depreciation & Amortization (CF) (2016 - 2025)

International Stem Cell (ISCO) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $56000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 5.66% to $56000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $219000.0, a 9.5% increase, with the full-year FY2024 number at $206000.0, up 6.19% from a year prior.
  • Depreciation & Amortization (CF) was $56000.0 for Q3 2025 at International Stem Cell, up from $54000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $67000.0 in Q4 2021 to a low of $47000.0 in Q3 2023.
  • A 5-year average of $55000.0 and a median of $54000.0 in 2024 define the central range for Depreciation & Amortization (CF).
  • Peak YoY movement for Depreciation & Amortization (CF): fell 22.39% in 2022, then grew 12.77% in 2024.
  • International Stem Cell's Depreciation & Amortization (CF) stood at $67000.0 in 2021, then dropped by 22.39% to $52000.0 in 2022, then fell by 7.69% to $48000.0 in 2023, then increased by 12.5% to $54000.0 in 2024, then increased by 3.7% to $56000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Depreciation & Amortization (CF) are $56000.0 (Q3 2025), $54000.0 (Q2 2025), and $55000.0 (Q1 2025).